As such, the reduction in DAP10 transcription in CLL-NK cells is sufficient to account for the observation of decreased NKG2D expression and impaired NKG2D-specific killing by CLL-NK cells (Figure 2). Here, KLRK1 is linked to B-cell chronic lymphocytic leukemia.